Evidence map›Paper›PMID 20707610›Full record

ArticleBiological chemistry2010

Multiplex analysis of mitochondrial DNA pathogenic and polymorphic sequence variants.

Jason C Poole, Vincent Procaccio, Martin C Brandon, Greg Merrick, Douglas C Wallace

Abstract read
In one paragraph

Article in Biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Protecting the mitochondrial powerhouse.Trends in cell biology · 2015
    Review
  3. Article
  4. Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jason C PooleCenter for Molecular and Mitochondrial Medicine and Genetics, University of California, Irvine, CA 92697, USA.
Vincent Procaccio
Martin C Brandon
Greg Merrick
Douglas C Wallace

Funding

UC Irvine Alzheimer's Disease Research Center Induced Pluripotent Stem Cell CoreP50AG016573 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAFERLA, FRANK M · 2000 to 2019
$37.0M
TISSUE REPOSITORY COREP01AG000538 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI POON, WAYNE W · 1985 to 2018
$24.8M
MITOCHONDRIAL INBORN ERRORS OF METABOLISMR01NS021328 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI WALLACE, DOUGLAS C · 1985 to 2017
$6.5M
Adaptive Physiology of mtDNA Longevity MutationsR01AG024373 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI WALLACE, DOUGLAS C · 2004 to 2008
$1.9M
Mitochondrial Diabetes & Manganic Porphyrin TreatmentR01DK073691 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI WALLACE, DOUGLAS C · 2006 to 2010
$1.5M
Mitochondrial Regulated Longevity Assurance GenesF32AG025638 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI POOLE, JASON C · 2004 to 2006
$134k
NIA NIH HHS AG16573NIA NIH HHS AG24373NIA NIH HHS AG25638NIA NIH HHS F32 AG025638NIA NIH HHS P01 AG000538NIA NIH HHS P50 AG016573NIA NIH HHS R01 AG024373NIDDK NIH HHS DK73691NIDDK NIH HHS R01 DK073691NINDS NIH HHS NS21328NINDS NIH HHS R01 NS021328
6 · The paper itself

Abstract

The mitochondrial DNA (mtDNA) encompasses two classes of functionally important sequence variants: recent pathogenic mutations and ancient adaptive polymorphisms. To rapidly and cheaply evaluate both classes of single nucleotide variants (SNVs), we have developed an integrated system in which mtDNA SNVs are analyzed by multiplex primer extension using the SNaPshot system. A multiplex PCR amplification strategy was used to amplify the entire mtDNA, a computer program identifies optimal extension primers, and a complete global haplotyping system is also proposed. This system genotypes SNVs on multiplexed mtDNA PCR products or directly from enriched mtDNA samples and can quantify heteroplasmic variants down to 0.8% using a standard curve. With this system, we have developed assays for testing the common pathogenic mutations in four multiplex panels: two genotype the 13 most common pathogenic mtDNA mutations and two genotype the 10 most common Leber Hereditary Optic Neuropathy mutations along with haplogroups J and T. We use a hierarchal system of 140 SNVs to delineate the major global mtDNA haplogroups based on a global phylogenetic tree of coding region polymorphisms. This system should permit rapid and inexpensive genotyping of pathogenic and lineage-specific mtDNA SNVs by clinical and research laboratories.

Indexed as

AllelesCell Line, TumorDNA, MitochondrialDNA PrimersHaplotypesHumansInternetPhylogenyPolymerase Chain ReactionPolymorphism, Single NucleotidePseudogenesDNA, MitochondrialDNA Primers

Identifiers

PMID20707610
PMCPMC4023691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.